RU2026080C1 - Remedy for treatment of conjunctivitis - Google Patents
Remedy for treatment of conjunctivitis Download PDFInfo
- Publication number
- RU2026080C1 RU2026080C1 RU92015326A RU92015326A RU2026080C1 RU 2026080 C1 RU2026080 C1 RU 2026080C1 RU 92015326 A RU92015326 A RU 92015326A RU 92015326 A RU92015326 A RU 92015326A RU 2026080 C1 RU2026080 C1 RU 2026080C1
- Authority
- RU
- Russia
- Prior art keywords
- conjunctivitis
- treatment
- remedy
- insulin
- medicine
- Prior art date
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Изобретение относится к медицине, а именно к офтальмологии при лечении конъюнктивита. The invention relates to medicine, namely to ophthalmology in the treatment of conjunctivitis.
Известны способы лечения конъюнктивита (Краснов М. Терапевтическая офтальмология, М. : Медицина, 1985, с. 58, Аветисов Э., Справочник по офтальмологии, М.: Медицина, 1978, с. 118-124 и т.д. Known methods of treating conjunctivitis (Krasnov M. Therapeutic ophthalmology, M.: Medicine, 1985, p. 58, Avetisov E., Handbook of Ophthalmology, M .: Medicine, 1978, p. 118-124, etc.
Недостатками известных средств, используемых при данном заболевании, является длительность их применения - 2-4 недели и более. The disadvantages of the known drugs used for this disease is the duration of their use - 2-4 weeks or more.
Целью изобретения является ускорение лечебного эффекта, позволяющего в течение 2-3 сут устранить проявление конъюнктивита. The aim of the invention is to accelerate the therapeutic effect, allowing within 2-3 days to eliminate the manifestation of conjunctivitis.
Способ осуществляется путем применения по новому назначению известного ранее и разрешенному Фармакологическим Комитетом в разрешенных дозах лекарства - инсулина в виде местно применяемых инстилляций по 3 капли в каждый глаз 4 раза в сутки. The method is carried out by applying for a new purpose the previously known and permitted by the Pharmacological Committee in the authorized doses of the drug - insulin in the form of topically applied instillations of 3 drops in each eye 4 times a day.
Инсулин обладает способностью усиливать иммунитетную активность лимфоцитов. Назначение инсулина местно улучшает неспецифическую иммунную защиту глаз, что приводит к ускорению лечебного эффекта - устранению проявлений конъюнктивита. Insulin has the ability to enhance the immune activity of lymphocytes. The administration of insulin locally improves the non-specific immune protection of the eyes, which leads to an acceleration of the therapeutic effect - the elimination of manifestations of conjunctivitis.
Инсулин стимулирует в организме человека фагоцитарную активность лимфоцитов, восстанавливает местный иммунитет, что позволяет ускорить при местном применении его на конъюнктиву глаза устранение проявлений заболевания. Insulin stimulates the phagocytic activity of lymphocytes in the human body, restores local immunity, which makes it possible to accelerate the elimination of the manifestations of the disease when applied topically to the conjunctiva of the eye.
Средство прошло клиническую апробацию. Средство, предлагаемое в данном предложении, иллюстрируется клиническим примером. The tool has passed clinical testing. The tool proposed in this proposal is illustrated by a clinical example.
Противопоказания - аллергия к инсулину. Contraindications - allergy to insulin.
Способ применен у 10 больных с положительным эффектом. The method was applied in 10 patients with a positive effect.
П р и м е р. Больной Н., 29 лет. Заболел 22.08.92 г., когда появились светобоязнь, отек и покраснение кожи век, умеренный блефароспазм, гиперемия конъюнктивы, скудное негнойное отделяемое. Назначение инстилляций инсулина по 3 капли в каждый глаз 4 раза в сутки. Через 2 сут проявления конъюнктивита исчезли. PRI me R. Patient N., 29 years old. He became ill on August 22, 1992, when photophobia, edema and redness of the skin of the eyelids, mild blepharospasm, conjunctival hyperemia, and poor purulent discharge appeared. The appointment of insulin instillations in 3 drops in each eye 4 times a day. After 2 days, the manifestations of conjunctivitis disappeared.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU92015326A RU2026080C1 (en) | 1992-12-30 | 1992-12-30 | Remedy for treatment of conjunctivitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU92015326A RU2026080C1 (en) | 1992-12-30 | 1992-12-30 | Remedy for treatment of conjunctivitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2026080C1 true RU2026080C1 (en) | 1995-01-09 |
| RU92015326A RU92015326A (en) | 1996-04-20 |
Family
ID=20134729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU92015326A RU2026080C1 (en) | 1992-12-30 | 1992-12-30 | Remedy for treatment of conjunctivitis |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2026080C1 (en) |
-
1992
- 1992-12-30 RU RU92015326A patent/RU2026080C1/en active
Non-Patent Citations (1)
| Title |
|---|
| Аветисов Э. Справочник по офтальмологии. М.: Медицина, 1978, 118-124. * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE230985T1 (en) | USE OF XANTHOPHYLLES IN THE PRODUCTION OF MEDICINAL PRODUCTS TO IMPROVE MUSCLE FUNCTIONAL DURATION OR TO TREAT MUSCLE DISORDERS OR DISEASES | |
| US3549770A (en) | Therapeutic administration of effective amounts of dimethyl sulfoxide to human and animal subjects | |
| BR9507858A (en) | Application of a prolactin inhibiting compound to prepare a medicament for the treatment of an immune system dysfunction application of a prolactin stimulating compound to prepare a medicament for the treatment of an immune system dysfunction medicine for the treatment of an autoimmune disease and therapeutic package | |
| WO1999066948A3 (en) | Use of a dipeptide for stimulating repair processes | |
| DE69602412D1 (en) | Ophthalmic preparation for the treatment or prevention of dry eye and diseases caused thereby, containing 12-sulfodehydroabietic acid | |
| RU94045825A (en) | Use of material obtained from mycobacterium vaccae for production of therapeutic agent used for psychiatric disease treatment, method of psychiatric disease treatment, product containing antigenic and/or immunoregulating material, pharmaceutical agent | |
| DE68926115D1 (en) | METHOD FOR TREATING ACNE | |
| RU2026080C1 (en) | Remedy for treatment of conjunctivitis | |
| EP0304294A2 (en) | Taliscanin and other Aristolactams for treating neurological disorders, Parkinson's disease, Alzheimer disease and impotence | |
| US3790682A (en) | Ataractic use of dimethyl sulfoxide | |
| ES2042818T3 (en) | THERAPEUTIC AGENT FOR THROMBOCITOPENIA. | |
| RU2120263C1 (en) | Method for carrying out conservative treatment of burned eyes | |
| RU2067446C1 (en) | Method for treating pain syndrome in the cases of trifacial neuralgia and extremity stump phantom pain | |
| SU1169655A1 (en) | Method of treatment of thrombolytic diseases of the artery of the extremities | |
| SU1706624A1 (en) | Method for curing opiumism and morphinism | |
| EISENBERG | Contact dermatitis from selenium sulfide shampoo | |
| SU1156700A1 (en) | Method of treatment of neuroses | |
| SU827081A1 (en) | Method of treating vasomotor headache | |
| RU2034529C1 (en) | Method for applying reflex action in treatment of vibration sickness | |
| SU1602522A1 (en) | Method of treating psoriatic arthropathy patients | |
| RU2031655C1 (en) | Remedy for treatment of tonsillitis | |
| EP0876147A1 (en) | Use of galanthamine in the preparation of novel drugs | |
| Bennett | The introduction of curare into clinical medicine: present and potential usefulness | |
| RU2000779C1 (en) | Method of curing vitiligo | |
| RU2137460C1 (en) | Method for restoring mimic muscle function |